Novel HIV vaccine now in Zambia

By NATION REPORTER THE United States has delivered the first doses of lenacapavir, a ground-breaking HIV-prevention drug produced by American pharmaceutical company Gilead Sciences, marking a major milestone in efforts to curb new infections in high-burden countries, including Zambia. The doses arriving in eSwatini and Zambia form part of a market-shaping initiative under the U.S. […]